EBA
BIO icon

Eagle Bay Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Eagle Bay Advisors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-30
Closed -$14.4K – 851
2023
Q1 		$14.4K Hold
30
– – 0.01% 558
2022
Q4 		$12.6K Hold
30
– – 0.01% 584
2022
Q3 		$13K Hold
30
– – 0.01% 563
2022
Q2 		$14.8K Buy
+30
New +$15.6K 0.01% 594
2022
Q1 		– Sell
-30
Closed -$23K – 372
2021
Q4 		$23K Hold
30
– – 0.01% 532
2021
Q3 		$22K Hold
30
– – 0.01% 597
2021
Q2 		$20K Buy
+30
New +$18.3K 0.02% 544

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Eagle Bay Advisors's BIO Position: Q2 2023 in Review

Eagle Bay Advisors sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2023, closing a stake of 30 shares — an estimated $14.4K sold.

Eagle Bay Advisors first reported a position in BIO in Q2 2021 and held it in 7 quarters. The position peaked at $23K in Q4 2021. 469 funds tracked by Wall St. Rank hold BIO as of Q2 2023.

  • Eagle Bay Advisors reported no remaining Bio-Rad Laboratories Class A position as of Q2 2023 after selling out during the quarter.
  • Eagle Bay Advisors sold 30 Bio-Rad Laboratories Class A shares in Q2 2023, an estimated $14.4K.
  • Eagle Bay Advisors first reported a position in Bio-Rad Laboratories Class A in Q2 2021 and held it in 7 quarters.
  • Eagle Bay Advisors's Bio-Rad Laboratories Class A position peaked at $23K in Q4 2021.
  • 469 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2023.

Based on Eagle Bay Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.